CLBIO.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 10:07):

Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications...

Stats
Today's Volume	502.00
Average Volume	10 070.00
Market Cap	223.50M
EPS	SEK0 ( 2024-02-13 )
Next earnings date	( SEK0 ) 2024-04-29
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-260.00
ATR14	SEK0.0320 (0.31%)

Corline Biomedical AB Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Corline Biomedical AB Financials

Annual	2023
Revenue:	SEK25.03M
Gross Profit:	SEK-459 000 (-1.83 %)
EPS:	SEK-0.0842

Q4	2023
Revenue:	SEK6.24M
Gross Profit:	SEK-21 000.00 (-0.34 %)
EPS:	SEK-0.0279

Q3	2023
Revenue:	SEK5.31M
Gross Profit:	SEK7.20M (135.61 %)
EPS:	SEK0.00830

Q2	2023
Revenue:	SEK6.08M
Gross Profit:	SEK5.48M (90.08 %)
EPS:	SEK-0.110

Financial Reports:

No articles found.

Corline Biomedical AB

Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. Its products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used as stand-alone pharmaceutical compound. The company's products include Renaparin for use in the treatment of end stage renal failure; Cytoparin, a cell therapy that is used for the treatment of patients with type 1 diabetes; CHC, which is used for the treatment of soft tissue injuries; medical devices; and CHS, a coronary stent. The company was founded in 1991 and is based in Uppsala, Sweden.